Search

Search Constraints

You searched for: Issue Volume 259(2020)

Search Results

762. The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways. (15th September 2020)